Form 4 for AVTR Avantor, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2023-01-02 · accession 0001722482-23-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-04 | 2023-01-02 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $21.09 | -6,727 | 90.2K | -7% | -$141.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-02 | F | D | 6,727 | $21.09 | 90,208 | D | — | — |